Furthermore, in functional xenograft assays, NSG mice engrafted with more immature CD99-positive CD34+CD38− AML LSCs rapidly developed fatal myeloid leukemia, whereas engraftment with CD34+CD38− CD99-negative cells resulted in normal lympho-myeloid development. This evidence concerns the gene CD34 and myeloid leukemia.